Clinical Trials Logo

Clinical Trial Summary

Patients with chronic kidney disease (CKD) have a higher risk of fractures than those without. The purpose of this study is to develop a non-invasive Magnetic resonance imaging (MRI) method that can improve fracture risk prediction and provide early diagnosis for bone abnormalities in patients with CKD.


Clinical Trial Description

Chronic Kidney Disease-Mineral and Bone Disorder (MBD) is a common complication of chronic kidney disease (CKD), which may lead to defective mineralization, altered bone morphology, and/or bone turnover. Animal research found that bone changes occur even in the early stage of CKD , and with CKD progression, the patient may show symptoms such as bone pain, joint pain, bone deformation, and even spontaneous fractures.

Despite significant advances in understanding bone disease in CKD, most clinical and biochemical targets used in clinical practice remain controversial, resulting in an undermanagement of bone fragility.Our ability to diagnose CKD-MBD and to initiate strategies that could prevent fractures remains limited by the lack of accurate and noninvasive diagnostic tools.

The purpose of this study is to develop a non-invasive method that can improve fracture risk prediction and provide early diagnosis for bone abnormalities in patients with CKD. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04564924
Study type Observational
Source Tongji Hospital
Contact yan Xiong, PhD
Phone 15549460070
Email 313857231@qq.com
Status Recruiting
Phase
Start date September 2, 2020
Completion date January 30, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04714918 - Chinese CKD-MBD Prevalence Survey (CRISS-MBD)
Recruiting NCT06288451 - DePTH: De-emphasize PTH Phase 2
Completed NCT04750460 - Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa). Phase 3
Recruiting NCT05439980 - Improving Phosphate Control in Children With CKD
Recruiting NCT05096195 - PRevEnting FracturEs in REnal Disease 1 Phase 4
Completed NCT05399251 - Relationship Between Serum 1,25-dihydroxy Vitamin D and Markers of Bone Metabolism in Renal Dysfunction Patients
Recruiting NCT05242055 - Integrated Diagnosis and Treatment of CKD on Outcomes
Recruiting NCT04522622 - Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease Phase 4
Recruiting NCT05720273 - Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients Phase 4